We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cites Rhode Island Drugmaker for Multiple Violations
FDA Cites Rhode Island Drugmaker for Multiple Violations
Quality violations at Tedor Pharma’s Cumberland, Rhode Island site netted the drugmaker a Form 483 from the FDA for inadequate testing, cleaning and calibration procedures.